Median Diagnostics Inc. Logo

Median Diagnostics Inc.

Develops and supplies in-vitro diagnostic products and raw materials for animal diseases.

233250 | KO

Overview

Corporate Details

ISIN(s):
KR7233250000
LEI:
Country:
South Korea
Address:
강원도 춘천시 동내면 순환대로 878, 춘천시

Description

Median Diagnostics Inc. specializes in the development, manufacturing, and supply of in-vitro diagnostic products for animal diseases. The company provides a comprehensive portfolio of diagnostic solutions, including ELISA and PCR kits, rapid tests, and standard reagents. It also produces essential raw materials such as monoclonal antibodies and antigens. A primary focus is on offering 'Total Diagnostic Systems' for high-consequence animal diseases, including African Swine Fever (ASF), Foot-and-Mouth Disease (FMD), High Pathogenicity Avian Influenza (HPAI), Porcine Epidemic Diarrhea (PED), and Bovine Viral Diarrhea (BVD). The company also supplies raw materials for human disease diagnostic applications.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-03-19 00:00
정기주주총회결과
Korean 16.2 KB
2025-03-11 00:00
감사보고서제출
Korean 15.9 KB
2025-03-11 00:00
사업보고서 (2024.12)
Korean 377.2 KB
2025-03-07 00:00
주식등의대량보유상황보고서(일반)
Korean 89.7 KB
2025-03-07 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-03-04 00:00
주주총회소집공고
Korean 131.2 KB
2025-02-19 00:00
주주총회소집결의
Korean 7.3 KB
2025-01-21 00:00
주식등의대량보유상황보고서(일반)
Korean 79.6 KB
2025-01-21 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.6 KB
2025-01-09 00:00
주식등의대량보유상황보고서(일반)
Korean 80.2 KB
2025-01-09 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.6 KB
2025-01-08 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.6 KB
2024-12-23 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.6 KB
2024-12-20 00:00
주식등의대량보유상황보고서(일반)
Korean 82.5 KB
2024-12-20 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB

Automate Your Workflow. Get a real-time feed of all Median Diagnostics Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Median Diagnostics Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Median Diagnostics Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.